Literature DB >> 30702791

Modifiable risk factors for community-acquired pneumonia in children under 5 years of age in resource-poor settings: a case-control study.

James Samwel Ngocho1, Marien Isaäk de Jonge2, Linda Minja3, Gaudencia Alois Olomi4, Michael Johnson Mahande1, Sia Emmanueli Msuya1,5, Blandina Theophile Mmbaga3.   

Abstract

OBJECTIVE: Despite the availability of vaccines and antibiotics, pneumonia remains the leading cause of mortality among children under 5 years of age. The objective of this study was to identify modifiable risk factors for community-acquired pneumonia (CAP) in children under 5 years of age in a vaccinated population.
METHODS: A case-control study was conducted between January and December 2017. The cases included children aged 2-59 months with X-ray-confirmed pneumonia, whereas the controls were children from the community with no history of respiratory infection. A multivariable logistic regression model was used to determine the modifiable risk factors for CAP.
RESULTS: A total of 113 children with X-ray-confirmed pneumonia and 350 healthy children were enrolled in this study. The median ages for the cases and controls were 13.7 (IQR = 7.2-25.3) and 13.4 (IQR = 6.0-24.8) months respectively. One (0.9%) child died after the enrolment. The independent predictors of CAP included a lack of exclusive breastfeeding for 6 months (aOR = 1.7, 95% CI = 1.0-2.9), underweight (aOR = 2.1, 95% CI = 1.0-4.5), unclean cooking fuel (aOR = 1.8, 95% CI = 1.0-3.3) and low income (aOR = 2.9, 95% CI = 1.6-5.4). No association was found between vaccination status and CAP.
CONCLUSION: In addition to a lack of exclusive breastfeeding, children from families of low-economic status were at risk of contracting CAP. Since the risk factors are complex, the study results call for more concerted efforts by and collaboration among the health, agriculture and development sectors to address mortality caused by CAP.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  Tanzania; Tanzanie; children under 5 years of age; community-acquired pneumonia; enfants de moins de cinq ans; facteurs de risque; pneumonie acquise en communauté; risk factors

Mesh:

Year:  2019        PMID: 30702791     DOI: 10.1111/tmi.13211

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  5 in total

1.  Determination of Procalcitonin, C-Reactive Protein and White Blood Cell Levels to Diagnose Community-Acquired Pneumonia (CAP).

Authors:  Fuyong Jiao; Jianping Chen; Mengmeng Wang; Senthil Arun Kumar; Xiaohong Li; Tiantian Han
Journal:  Indian J Pediatr       Date:  2019-04-04       Impact factor: 1.967

2.  Viral-bacterial (co-)occurrence in the upper airways and the risk of childhood pneumonia in resource-limited settings.

Authors:  James S Ngocho; Linda Minja; Christa E van der Gaast-de Jongh; Janette C Rahamat-Langendoen; Jeroen D Langereis; Blandina T Mmbaga; Marien I de Jonge
Journal:  J Infect       Date:  2020-06-10       Impact factor: 6.072

3.  Inappropriate treatment of community-acquired pneumonia among children under five years of age in Tanzania.

Authors:  James Samwel Ngocho; Pius Gerald Horumpende; Marien Isaäk de Jonge; Blandina Theophil Mmbaga
Journal:  Int J Infect Dis       Date:  2020-01-23       Impact factor: 3.623

4.  Using geo-spatial analysis for assessing the risk of hospital admissions due to community-acquired pneumonia in under-5 children and its association with socially vulnerable areas (Brazil).

Authors:  Juliana Coelho Pina; Luana Seles Alves; Luiz Henrique Arroyo; Ricardo Alexandre Arcêncio; Ellen Cristina Gondim; Maria Cândida de Carvalho Furtado; Débora Falleiros de Mello
Journal:  BMC Pediatr       Date:  2020-11-03       Impact factor: 2.125

5.  Factors associated with community acquired severe pneumonia among under five children in Dhaka, Bangladesh: A case control analysis.

Authors:  Sabiha Nasrin; Md Tariqujjaman; Marufa Sultana; Rifat A Zaman; Shahjahan Ali; Mohammod J Chisti; Abu S G Faruque; Tahmeed Ahmed; George J Fuchs; Niklaus Gyr; Nur H Alam
Journal:  PLoS One       Date:  2022-03-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.